MDAI vs. SKIN, KRMD, MGRM, INFU, OBIO, MBOT, STSS, ICAD, EDAP, and MLSS
Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Beauty Health (SKIN), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), InfuSystem (INFU), Orchestra BioMed (OBIO), Microbot Medical (MBOT), Sharps Technology (STSS), iCAD (ICAD), Edap Tms (EDAP), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry.
Spectral AI vs.
Spectral AI (NASDAQ:MDAI) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.
Beauty Health has a net margin of -8.11% compared to Spectral AI's net margin of -40.78%. Spectral AI's return on equity of 0.00% beat Beauty Health's return on equity.
Spectral AI has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.
Spectral AI currently has a consensus price target of $4.75, indicating a potential upside of 269.65%. Beauty Health has a consensus price target of $2.50, indicating a potential upside of 141.55%. Given Spectral AI's stronger consensus rating and higher possible upside, equities research analysts plainly believe Spectral AI is more favorable than Beauty Health.
Beauty Health received 33 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 45.45% of users gave Beauty Health an outperform vote.
67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 56.7% of Spectral AI shares are owned by company insiders. Comparatively, 41.0% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Spectral AI has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.
In the previous week, Beauty Health had 17 more articles in the media than Spectral AI. MarketBeat recorded 22 mentions for Beauty Health and 5 mentions for Spectral AI. Spectral AI's average media sentiment score of 0.92 beat Beauty Health's score of 0.67 indicating that Spectral AI is being referred to more favorably in the media.
Summary
Spectral AI beats Beauty Health on 11 of the 19 factors compared between the two stocks.
Get Spectral AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral AI Competitors List
Related Companies and Tools
This page (NASDAQ:MDAI) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy MDAI Stock Free MDAI Stock Alerts